Displaying 1321 - 1340 of 1557
FTC Staff Opposes Alaska Physicians' Health Plan Legislation:
Staff Advisory Opinion:
FTC Agreement with American Home Products Corp. Would Protect Consumers from Anticompetitive Practices
Roche Holding Ltd, In the Matter of
Roche agreed to divest, certain assets in the U.S. and Canada to settle antitrust concerns stemming from its proposed acquisition of Corange Limited. The consent order permits the acquisition but requires the divestiture of Cardiac thrombolytic agents (drugs used to treat heart attack victims) and ongoing business assets relating to chemicals used to test for the presence of illegal or abused drugs.
FTC Staff Opposes Washington State Proposal to Allow Physician Collective Bargaining
FTC Staff Opposes Alaska Proposal to Allow Physician Collective Bargaining
Announced Actions for January 9, 2002
In re: Buspirone Antitrust Litigation MDL
In re: First Databank Antitrust Litigation
Non-profit Institutions Act Covers Pharmaceuticals Dispensed to Retired Employees, FTC Staff Advises
Hearst Corp. To Disgorge $19 Million and Divest Business to Facts and Comparisons to Settle FTC Complaint
Hearst Trust, The, The Hearst Corporation, and First DataBank, Inc.
The Commission negotiated an agreement with The Hearst Corporation (Hearst) to settle a permanent injunction action filed by the FTC alleging that Hearst failed to provide documents required by premerger notification law and then consummated a merger that monopolized the integrated drug information database market. Under the terms of the order, Hearst divested the Medi-Span business to Lippincott Williams & Wilkins, Inc. , a subsidiary of Wolters Kluwer, n.v., disgorged $19 million in profits, and to complied with certain other obligations.
Statement of Susan A. Creighton, Deputy Director, Bureau of Competition Regarding FTC Settlement with Hearst Corporation
Staff Summary of Federal Trade Commission Activities Affecting Older Americans: January 1999-August 2001: A Commission Staff Report to the United States Senate Special Committee on Aging
Prepared Statement of the Federal Trade Commission On Competition in the Pharmaceutical Marketplace
Antitrust Issues in the Settlement of Pharmaceutical Patent Disputes, Part II
Hoechst Marion Roussel, Inc.; Carderm Capital L.P.; and Andrx Corporation
A consent order settled allegations in an administrative complaint that charged that Hoechst agreed to pay Andrx Corporation millions of dollars not to market and distribute a generic version of Hoechst’s branded Cardizem CD, a once-a-day diltiazem drug product used in the treatment of hypertension and angina. The consent order prohibits the companies from entering into agreements designed to restrict the entry of generic competitors in an attempt to monopolize relevant markets .
Announced Actions for April 30, 2001
Alaska Healthcare Network, Inc.
An association of 86 physicians practicing in the Fairbanks, Alaska area settled charges that the Alaskan Healthcare Network illegally formulated a fee schedule based on its members’ current prices for use in negotiations with third-party payers in an effort to obtain higher prices for medical services.
Displaying 1321 - 1340 of 1557